Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.

Journal of virology - 9 Dec 2020

Manzoor Rashid, Eguchi Nao, Yoshida Reiko, Ozaki Hiroichi, Kondoh Tatsunari, Okuya Kosuke, Miyamoto Hiroko, Takada Ayato

Abstract excerpt

Protective immunity against influenza A viruses (IAVs) generally depends on antibodies to the major envelope glycoprotein, hemagglutinin (HA), whose antigenicity is distinctive among IAV subtypes. On the other hand, the matrix 2 (M2) protein is antigenically highly conserved and has been studied as an attractive vaccine antigen to confer cross-protective immunity against multiple subtypes of IAVs. However,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acids
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antibodies, Viral

Share to Hemagglutinin Glycoproteins, Influenza Virus

Share to Influenza A virus

Share to Madin Darby Canine Kidney Cells

Share to Viral Matrix Proteins

Share to Virus Release

Source

Open in PubMed Open full text

Identifiers

PMID: 33055251
DOI: 10.1128/JVI.01277-20
PMCID: PMC7737731

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Mechanism Underlying Antiviral Activity of an Influenza Virus M2-Specific Antibody.PMID 33055251Read ↗

Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine developmentSemantic proximity Read ↗

A Low-Dose Triple Antibody Cocktail Against the Ectodomain of the Matrix Protein 2 of Influenza A Is A Universally Effective and Viral Escape Mutant Resistant Therapeutic AgentSemantic proximity Read ↗

Monoclonal antibody recognizing SLLTEVET epitope of M2 protein potently inhibited the replication of influenza A viruses in MDCK cells.Semantic proximity Read ↗

Fc-dependent protective efficacy of non-inhibitory antibodies targeting influenza A virus neuraminidase is limited by epitope availabilitySemantic proximity Read ↗

Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase.Semantic proximity Read ↗

Non-neutralizing antibody responses to vesicular stomatitis virus-vectored influenza A virus vaccines correlate with protectionSemantic proximity Read ↗

Hemagglutinin Stalk-based Monoclonal Antibody Elicits Broadly Reactivity Against Group 1 Influenza A VirusSemantic proximity Read ↗

Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A virusesSemantic proximity Read ↗

In Vivo Therapy with M2e-Specific IgG Selects for an Influenza A Virus Mutant with Delayed Matrix Protein 2 Expression.Semantic proximity Read ↗

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B virusesSemantic proximity Read ↗

Anti-Matrix Protein 1 Monoclonal Antibody Neutralizes Influenza A Virus SubtypesSemantic proximity Read ↗

A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.